Cardiovascular Genetics tests in Dubai & UAE

Compare available Cardiovascular Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,300.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Cardiovascular Genetics test prices

Showing 16–30 of 39 matching tests.

Cardiovascular Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4411 KCNA5 Gene Atrial Fibrillation Type 7 Genetic Test This genetic test identifies pathogenic variants in the KCNA5 gene associated with familial atrial fibrillation type 7.	Peripheral whole blood	3-4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNA5 gene", "Copy number variants in the KCNA5 gene"] Parameters [] Preparation ["A clinical history review is required", "A formal genetic counselling session is mandatory"] Indications ["Personal or strong family history of early-onset atrial fibrillation", "Individuals developing atrial fibrillation without typical risk factors"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: I48.91 Clinical summary This genetic test identifies pathogenic variants in the KCNA5 gene associated with familial atrial fibrillation type 7.
TEST-4175 KCNE1 Gene Long QT Syndrome Type 5 Genetic Test This test identifies pathogenic variants in the KCNE1 gene associated with Long QT Syndrome Type 5.	Peripheral whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNE1 gene"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counselling session"] Indications ["Personal or family history of unexplained syncope", "Personal or family history of sudden cardiac arrest", "Prolonged QT interval on ECG", "Cascade testing of relatives after a positive diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81313-1 ICD-10: I45.81 Clinical summary This test identifies pathogenic variants in the KCNE1 gene associated with Long QT Syndrome Type 5.
TEST-4418 KCNE2 Gene Atrial Fibrillation Type 4 Genetic Test This test evaluates the KCNE2 gene for pathogenic variants associated with hereditary atrial fibrillation type 4.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNE2 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation ["Genetic counselling session is mandatory", "Fasting not required", "Do not stop anticoagulants without cardiologist instruction"] Indications ["Individuals with a strong family history of early-onset atrial fibrillation", "Individuals with unexplained sudden cardiac events", "Athletes", "Individuals with lone atrial fibrillation before age 60", "Families with multiple affected members"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: I48.91 Clinical summary This test evaluates the KCNE2 gene for pathogenic variants associated with hereditary atrial fibrillation type 4.
TEST-4383 KCNE3 Gene Brugada Syndrome Type 6 Genetic Test This genetic test evaluates the KCNE3 gene for pathogenic variants associated with Brugada syndrome type 6.	Whole Blood (Peripheral) – EDTA tube	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNE3 gene", "Single nucleotide variants", "Small insertions/deletions", "Large deletions/duplications"] Parameters [] Preparation ["Mandatory genetic counselling session.", "No special fasting or medication changes required unless directed by physician."] Indications ["Suspicion of Brugada syndrome type 6", "Family history of Brugada syndrome", "Risk stratification for sudden cardiac death"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: I49.8 Clinical summary This genetic test evaluates the KCNE3 gene for pathogenic variants associated with Brugada syndrome type 6.
TEST-4149 KCNH2 Gene Short QT Syndrome Type 1 Genetic Test This test evaluates the KCNH2 gene for pathogenic variants associated with Short QT Syndrome Type 1.	Whole Blood (EDTA), Extracted DNA (≥2 µg), or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNH2 gene", "Presence of copy number variations (CNVs) in KCNH2"] Parameters [] Preparation [] Indications ["Diagnosis of Short QT Syndrome Type 1", "Cascade family screening for KCNH2 variants", "Risk stratification in individuals with suspected Short QT Syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81208-1 ICD-10: I49.8 Clinical summary This test evaluates the KCNH2 gene for pathogenic variants associated with Short QT Syndrome Type 1.
TEST-4145 KCNJ2 Gene Short QT Syndrome Type 3 (SQT3) Genetic Test This test evaluates the KCNJ2 gene for pathogenic variants associated with Short QT Syndrome Type 3 (SQT3), a rare inherited cardiac condition.	Peripheral whole blood (or dried blood spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNJ2 gene", "Coding exons and flanking splice sites of KCNJ2"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications being taken"] Indications ["Diagnosis of Short QT Syndrome Type 3", "Risk stratification for sudden cardiac arrest", "Family screening for KCNJ2 mutations", "Evaluation of individuals with unexplained syncope or palpitations"] Measurement technique Confirm with laboratory Codes LOINC: 92076-6 ICD-10: I45.82 Clinical summary This test evaluates the KCNJ2 gene for pathogenic variants associated with Short QT Syndrome Type 3 (SQT3), a rare inherited cardiac condition.
TEST-4214 KCNJ5 Gene Long QT Syndrome Type 13 Genetic Test This genetic test identifies pathogenic variants in the KCNJ5 gene associated with Long QT syndrome type 13.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNJ5 gene"] Parameters [] Preparation ["Genetic counselling is mandatory before sample collection"] Indications ["Diagnosis confirmation of Long QT syndrome type 13", "Family screening for Long QT syndrome type 13", "Risk stratification in individuals with suspected Long QT syndrome type 13"] Measurement technique Confirm with laboratory Codes LOINC: 21662-5 ICD-10: I45.81 Clinical summary This genetic test identifies pathogenic variants in the KCNJ5 gene associated with Long QT syndrome type 13.
TEST-4442 KCNQ1 Gene Atrial Fibrillation Type 3 Genetic Test This test evaluates the KCNQ1 gene for pathogenic variants associated with hereditary atrial fibrillation type 3.	Whole Blood (EDTA), Extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNQ1 gene"] Parameters [] Preparation [] Indications ["Diagnosis of hereditary atrial fibrillation type 3", "Risk assessment for individuals with family history"] Measurement technique Confirm with laboratory Codes LOINC: 80305-0 ICD-10: Z13.6 Clinical summary This test evaluates the KCNQ1 gene for pathogenic variants associated with hereditary atrial fibrillation type 3.
TEST-4201 KCNQ1 Gene Jervell and Lange-Nielsen Syndrome Type 1 Genetic Test This genetic test identifies pathogenic mutations in the KCNQ1 gene associated with Jervell and Lange-Nielsen Syndrome (JLNS), a form of long QT syndrome with congenital deafness.	Peripheral Blood (EDTA Whole Blood), Extracted DNA, or FTA Card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KCNQ1 gene mutations", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Clinical suspicion of JLNS", "Family history of JLNS", "Unexplained syncope", "Family history of sudden cardiac death", "Bilateral congenital deafness with prolonged QT interval on ECG"] Measurement technique Confirm with laboratory Codes LOINC: 94477-3 ICD-10: I45.81 Clinical summary This genetic test identifies pathogenic mutations in the KCNQ1 gene associated with Jervell and Lange-Nielsen Syndrome (JLNS), a form of long QT syndrome with congenital deafness.
TEST-4370 LMNA Gene Cardiomyopathy (Dilated Type 1A) Genetic Test This genetic test identifies pathogenic variants in the LMNA gene associated with dilated cardiomyopathy type 1A.	Peripheral Whole Blood (3–5 mL in EDTA tube) or DNA FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LMNA gene", "Structural variants in the LMNA gene"] Parameters [] Preparation ["No specific fasting required", "Continue prescribed medications"] Indications ["Patients with familial cardiomyopathy", "Risk stratification", "Cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 82248-7 ICD-10: I42.0 Clinical summary This genetic test identifies pathogenic variants in the LMNA gene associated with dilated cardiomyopathy type 1A.
TEST-6282 LPA Gene Coronary Artery Disease Susceptibility (Genetic Test) This genetic test evaluates the LPA gene for variants associated with elevated lipoprotein(a) levels, a known independent risk factor for premature coronary artery disease.	Whole Blood (Peripheral Venipuncture)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LPA gene variants", "Lipoprotein(a) levels (genetic predisposition)"] Parameters [] Preparation ["No fasting required"] Indications ["Family history of premature coronary artery disease", "Personal history of premature cardiovascular events", "Risk stratification for cardiovascular prevention"] Measurement technique Confirm with laboratory Codes LOINC: 21663-7 ICD-10: Z13.88, Z82.49 Clinical summary This genetic test evaluates the LPA gene for variants associated with elevated lipoprotein(a) levels, a known independent risk factor for premature coronary artery disease.
TEST-4051 MAT2A Gene Familial Thoracic Aortic Aneurysm DNA Test This test evaluates the MAT2A gene for pathogenic variants linked to familial thoracic aortic aneurysm risk.	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card Dried Blood Spot	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MAT2A gene", "Single nucleotide variants (SNVs)", "Small insertions or deletions (indels)"] Parameters [] Preparation ["Discontinue high-dose biotin (vitamin B7) supplements at least 72 hours before blood draw if advised by your clinician"] Indications ["First-degree relatives of individuals with confirmed thoracic aortic aneurysm or dissection", "Patients with syndromic features suggestive of hereditary aortopathy", "Adults seeking proactive cardiovascular risk assessment with a documented family history of aortic disease"] Measurement technique Confirm with laboratory Codes LOINC: 96458-9 ICD-10: I71.2, Z15.8 Clinical summary This test evaluates the MAT2A gene for pathogenic variants linked to familial thoracic aortic aneurysm risk.
TEST-4123 MED13L Gene Transposition of the Great Arteries, Dextro‑looped 1 Genetic Test This test identifies pathogenic variants in the MED13L gene associated with dextro-looped transposition of the great arteries (d-TGA).	Peripheral whole blood (3–5 mL in EDTA tube)	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MED13L gene", "Single-nucleotide variants", "Small indels"] Parameters [] Preparation ["No fasting or dietary restriction is necessary", "Provide recent echocardiogram report, surgical notes (if applicable), and a completed three-generation pedigree chart"] Indications ["Individuals with confirmed or suspected d-TGA", "At-risk first-degree relatives", "Preconception carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 94534-9 ICD-10: Q20.3 Clinical summary This test identifies pathogenic variants in the MED13L gene associated with dextro-looped transposition of the great arteries (d-TGA).
TEST-4354 MYH6 Gene Dilated Cardiomyopathy Type 1EE Genetic Test This genetic test identifies pathogenic variants in the MYH6 gene, which are linked to dilated cardiomyopathy type 1EE.	Whole Blood (3-5 mL), Extracted DNA, or FTA Card	3 - 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYH6 gene", "Cardiac beta-myosin heavy chain gene mutations"] Parameters [] Preparation [] Indications ["Diagnosis of dilated cardiomyopathy type 1EE", "Family cascade screening for MYH6 mutations", "Informed reproductive decisions", "Personalised cardiac care planning"] Measurement technique Confirm with laboratory Codes LOINC: 90569-1 ICD-10: I42.0 Clinical summary This genetic test identifies pathogenic variants in the MYH6 gene, which are linked to dilated cardiomyopathy type 1EE.
TEST-4393 PPP1R8 Gene Cardiac Defects Genetic Test This test identifies pathogenic variants within the PPP1R8 gene associated with inherited cardiac conditions like cardiomyopathies and congenital heart defects.	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [{"name": "PPP1R8 Gene Variants", "reference_range": "No pathogenic variants detected"}] Preparation ["Mandatory pre-test genetic counselling session.", "Construction of a detailed family pedigree."] Indications ["Patients with a family history of sudden cardiac death or structural heart abnormalities.", "Individuals with unexplained cardiomyopathies or congenital heart defects."] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: I42.9, Q24.9 Clinical summary This test identifies pathogenic variants within the PPP1R8 gene associated with inherited cardiac conditions like cardiomyopathies and congenital heart defects.

Category overview

Cardiovascular Genetics: overview

A family history of sudden heart issues or unexplained cardiovascular symptoms warrants proactive insights to protect your lifelong vitality before a medical emergency occurs. Representing a core pillar of our specialized Genetics services, Cardiovascular Genetics testing evaluates your DNA for inherited mutations linked to a wide range of cardiovascular conditions, from complex arrhythmias to structural defects like familial hypercholesterolemia. Utilizing state-of-the-art diagnostic technology, this vital molecular profiling helps uncover hidden risks, safely guiding highly personalized cardiac monitoring, preventative lifestyle adjustments, and targeted treatments. Widely respected for specialized cardiovascular diagnostics among top diagnostic labs in the UAE, DNA Labs guarantees absolute patient confidentiality, exceptional analytical precision, and incredibly efficient reporting. Safeguard your heart’s future—schedule your cardiovascular genetics testing in UAE, coordinate a comfortable home sample collection, or connect with our specialized cardiology team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.